Harpoon Therapeutics, Inc. (HARP) financial statements (2022 and earlier)

Company profile

Business Address 131 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:114,600150,000155,10089,493
Cash and cash equivalents44,68721,17088,73689,493
Short-term investments90,411104,86059,337 
Other undisclosed cash, cash equivalents, and short-term investments(20,498)23,9707,027 
Deferred costs200600  
Other undisclosed current assets22,895(20,846)(4,483)730
Total current assets:137,695129,754150,61790,223
Noncurrent Assets
Operating lease, right-of-use asset6,1276,5837,015
Property, plant and equipment9,24810,18811,3832,998
Long-term investments and receivables1,52223,9467,056 
Long-term investments1,52223,9467,056 
Other noncurrent assets8601,1215333,575
Other undisclosed noncurrent assets   5,784
Total noncurrent assets:17,75741,83825,98712,357
TOTAL ASSETS:155,452171,592176,604102,580
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities20,02815,41710,0897,698
Accounts payable2,6661,5722,5944,357
Accrued liabilities17,36213,8457,4953,341
Deferred revenue37,46231,29911,207
Debt  1,217 
Contract with customer, liability4,250
Other undisclosed current liabilities1,6491,202  
Total current liabilities:59,13947,91822,51311,948
Noncurrent Liabilities
Long-term debt and lease obligation10,53812,31313,727 
Operating lease, liability10,53812,31313,727
Liabilities, other than long-term debt27,70557,52246,14414,534
Deferred revenue27,70557,52246,144
Contract with customer, liability7,792
Other liabilities   6,742
Total noncurrent liabilities:38,24369,83559,87114,534
Total liabilities:97,382117,75382,38426,482
Temporary equity, carrying amount   129,577
Stockholders' equity
Stockholders' equity attributable to parent58,07053,83994,220(53,479)
Common stock4331
Additional paid in capital342,905221,904212,3399,111
Accumulated other comprehensive income (loss)(47)341 
Accumulated deficit(284,792)(168,071)(118,163)(62,591)
Total stockholders' equity:58,07053,83994,220(53,479)
TOTAL LIABILITIES AND EQUITY:155,452171,592176,604102,580

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues23,65417,4445,7774,750
Gross profit:23,65417,4445,7774,750
Operating expenses(140,405)(68,775)(63,983)(32,474)
Operating loss:(116,751)(51,331)(58,206)(27,724)
Nonoperating income301,4233,175358
Investment income, nonoperating2401,4493,217395
Other nonoperating expense(210)(26)(42)(37)
Loss before gain (loss) on sale of properties:(116,721)(49,908)(55,031)(27,366)
Other undisclosed net loss  (541) 
Net loss available to common stockholders, diluted:(116,721)(49,908)(55,572)(27,366)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(116,721)(49,908)(55,572)(27,366)
Other comprehensive income (loss)(50)(38)41 
Comprehensive loss, net of tax, attributable to parent:(116,771)(49,946)(55,531)(27,366)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: